Skip to main content
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
5.71
-0.03 (-0.52%)
At close: Mar 9, 2026, 4:00 PM EDT
5.61
-0.10 (-1.75%)
After-hours: Mar 9, 2026, 5:53 PM EDT

Artiva Biotherapeutics Revenue

In the year 2024, Artiva Biotherapeutics had annual revenue of $251.00K, down -99.25%.

Revenue (ttm)
$251.00K
Revenue Growth
-99.25%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
106
Market Cap
140.15M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024251.00K-33.24M-99.25%
Dec 31, 202333.49M28.56M579.21%
Dec 31, 20224.93M2.93M146.30%
Dec 31, 20212.00M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MacroGenics 127.63M
Spero Therapeutics 40.55M
Sangamo Therapeutics 32.88M
Zentalis Pharmaceuticals 26.87M
Innate Pharma 14.84M
Oramed Pharmaceuticals 2.00M
Connect Biopharma Holdings 762.00K
Adagene 103.20K
Revenue Rankings

ARTV News

More News